期刊
HEADACHE
卷 40, 期 8, 页码 657-661出版社
WILEY
DOI: 10.1046/j.1526-4610.2000.040008657.x
关键词
migraine; cognitive efficiency; sumatriptan; neuropsychological test
Background and Objectives.-The measurement of cognitive efficiency during migraine has produced conflicting results primarily due to the types of tests used, The objectives of this pilot study were two-fold: to measure cognitive efficiency during migraine, compared to a migraine-free period, and to evaluate the effects of therapy with a 5-HT1 agonist (sumatriptan injection, 6 mg) on the cognitive efficiency of migraineurs during a migraine, Method.-The Headache Care Center-Automated Neuropsychological Assessment Metrics was administered to 10 migraineurs, three times without a migraine, once during a migraine, and three times after administration of sumatriptan injection (6 mg), Results.-The results demonstrated a significant drop in cognitive efficiency during migraine and recovery 15 minutes after therapeutic injection. Conclusions.-This pilot study is the first to document a significant drop in cognitive functioning during migraine and recovery after administration of a migraine-specific medication.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据